Johnson and Johnson's (J&J) Chief Finance Officer Joseph Wolk said on Tuesday that the American pharmaceutical giant expects around $400 million in tariff-related costs this year, mostly pertaining to China.In a conference call with analysts discussing the company's latest earning results, Chief...
Johnson and Johnson (J&J) announced on Tuesday that its total sales in the first quarter of fiscal 2025 amounted to $21.9 billion, marking a 2.4% increase compared to the same period a year prior. The figure came in above the market expectations.The company's diluted earnings per share...
Earnings season kicks into gear this week as tech giants and banks prepare to release their financial results for the first quarter of fiscal 2025.One of the most prominent companies sharing its earnings report this week will be Netflix, which will publish its results on Thursday, with its revenue projected...
The shares of the American pharmaceutical company Johnson and Johnson (J&J) declined by more than 3% on Tuesday after US Bankruptcy Judge Christopher Lopez rejected the company's $10 billion proposal to resolve tens of thousands of lawsuits accusing J&J's baby powder and other talc...
Johnson and Johnson (J&J) announced on Friday in a press release that it will up its investments in the United States to more than $55 billion over the next four years, a 25% jump compared to the previous four-year period."Today's announcements accelerate our nearly 140-year legacy as an...
Johnson and Johnson (J&J) revealed on Wednesday that its total sales in the closing quarter of fiscal 2024 landed at $22.5 billion, booking a 5.3% growth compared to the prior-year quarter. The figure came in slightly above the market estimates. Meanwhile, its diluted earnings per share fell 17.1%...
Johnson & Johnson announced on Monday that it reached an agreement to buy biopharmaceutical company Intra-Cellular Therapies Inc. for around $14.6 billion or $132 per share in cash. J&J said it will fund the deal through a combination of cash on hand and debt and will provide an update on the...
Johnson & Johnson reported on Tuesday that its sales for the third quarter increased by 5.2% on a yearly basis, reaching $22.5 billion. Net earnings plunged 37.5% to $2.7 billion, with the diluted earnings per share (EPS) down 34.3% to $1.11. "Johnson & Johnson’s strong results in the third quarter...
Johnson & Johnson unveiled on Tuesday in a press release that it will be investing $2 billion in North Carolina to build a "state-of-the-art biologics manufacturing facility."Vice President of Innovative Medicine Supply Chain Dapo Ajayi stated that having a "strong, global supply chain" is of utmost...
Johnson & Johnson announced on Tuesday through a United States Securities and Exchange Commission (SEC) filing the departure of D. Scott Davis as director of the company.
"On September 10, 2024, D. S. Davis retired as a Director of Johnson & Johnson after the successful transition of Audit...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
